Personlized dendritic cell vaccine increases survival in patients with deadly brain cancer
Thursday, March 17, 2011 - 21:21
in Health & Medicine
A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study has found.
